Acutaas Chemicals Ltd Shows Strong Technical Momentum Amid Bullish Shift

Technical Momentum Shift and Market Context

Acutaas Chemicals, operating within the Pharmaceuticals & Biotechnology sector, currently trades at ₹1,717.00, slightly up from its previous close of ₹1,709.85. The stock’s 52-week high stands at ₹1,901.35, while the low is ₹919.63, indicating a robust recovery and sustained upward trajectory over the past year. Notably, the stock has outperformed the Sensex significantly, delivering a 67.6% return over the last 12 months compared to the Sensex’s 8.5% gain. Over three years, the stock’s return of 274.0% dwarfs the Sensex’s 39.1%, underscoring its strong growth profile.

The recent upgrade in the MarketsMOJO Mojo Grade from Hold to Buy on 6 October 2025, with a Mojo Score of 77.0, reflects improved confidence in the stock’s prospects. The Market Cap Grade remains modest at 3, consistent with its small-cap status, but the technical trend has shifted from mildly bullish to outright bullish, signalling enhanced momentum.

Moving Averages and Price Action

The daily moving averages for Acutaas Chemicals are firmly bullish, indicating that short-term price momentum is positive. The stock’s current price is comfortably above key moving averages, which often act as dynamic support levels. This alignment suggests that the upward trend is likely to continue unless disrupted by external factors.

Intraday price action on 19 January 2026 showed a high of ₹1,725.05 and a low of ₹1,689.60, with a modest day change of +0.42%. This steady upward movement within a relatively narrow range points to consolidation at higher levels, often a precursor to further gains.

MACD and KST Indicators: Mixed Weekly but Bullish Monthly Signals

The Moving Average Convergence Divergence (MACD) indicator presents a nuanced picture. On a weekly basis, the MACD remains mildly bearish, suggesting some short-term caution. However, the monthly MACD is bullish, indicating that the longer-term momentum is firmly positive. This divergence often signals a transitional phase where short-term volatility may persist before a sustained uptrend.

Similarly, the Know Sure Thing (KST) indicator is mildly bearish on the weekly chart but bullish on the monthly timeframe. This pattern reinforces the notion that while short-term price fluctuations may occur, the broader trend favours upward movement.

RSI and Bollinger Bands: Stability and Expansion

The Relative Strength Index (RSI) currently shows no significant signal on either weekly or monthly charts, implying that the stock is neither overbought nor oversold. This neutral RSI reading suggests room for further price appreciation without immediate risk of a reversal due to overextension.

Bollinger Bands, however, are bullish on both weekly and monthly timeframes. The bands are expanding, which typically indicates increasing volatility accompanied by a directional move. This expansion supports the view that Acutaas Chemicals is entering a phase of stronger price momentum.

Volume and Dow Theory Confirmation

On-Balance Volume (OBV) readings are bullish across weekly and monthly periods, signalling that volume trends are supporting price advances. This volume confirmation is critical as it suggests genuine buying interest rather than speculative spikes.

Dow Theory assessments show a mildly bullish weekly trend, though no clear trend is established monthly. This aligns with the mixed signals from other indicators, highlighting a short-term consolidation within a longer-term bullish framework.

Comparative Performance and Sector Context

Acutaas Chemicals’ returns over various periods have consistently outpaced the Sensex. For instance, the stock gained 1.7% in the past week while the Sensex was flat, and it rose 1.4% over the last month compared to the Sensex’s 1.3% decline. Year-to-date, the stock is up 0.8% while the Sensex has fallen 1.9%. These figures underscore the stock’s resilience and relative strength within the Pharmaceuticals & Biotechnology sector.

Its strong performance over three years, nearly 274%, is particularly notable given the sector’s competitive landscape and regulatory challenges. This outperformance suggests that Acutaas Chemicals is benefiting from favourable fundamentals and effective execution.

Investment Outlook and Ratings

With the MarketsMOJO Mojo Grade upgraded to Buy and a strong score of 77.0, Acutaas Chemicals is positioned as a compelling investment opportunity within the small-cap pharmaceutical space. The technical trend upgrade from mildly bullish to bullish, supported by daily moving averages and monthly MACD and Bollinger Bands, indicates a favourable risk-reward profile.

Investors should note the mild bearishness in some weekly indicators, which may translate into short-term volatility or consolidation phases. However, the overall technical and fundamental backdrop remains positive, with volume trends and price action confirming the strength of the uptrend.

Given the stock’s strong relative performance against the Sensex and its sector peers, alongside improving technical parameters, Acutaas Chemicals is well placed to continue its upward trajectory, provided broader market conditions remain supportive.

Key Technical Metrics Summary:

• Current Price: ₹1,717.00


• 52-Week Range: ₹919.63 – ₹1,901.35


• Daily Moving Averages: Bullish


• Weekly MACD: Mildly Bearish


• Monthly MACD: Bullish


• Weekly RSI: No Signal


• Monthly RSI: No Signal


• Weekly Bollinger Bands: Bullish


• Monthly Bollinger Bands: Bullish


• Weekly KST: Mildly Bearish


• Monthly KST: Bullish


• Weekly Dow Theory: Mildly Bullish


• Monthly Dow Theory: No Trend


• Weekly and Monthly OBV: Bullish

In conclusion, Acutaas Chemicals Ltd’s technical parameters and market performance signal a strengthening momentum phase. The upgrade in rating and positive monthly indicators provide a solid foundation for investors seeking exposure to a high-growth pharmaceutical small-cap with improving technical health.

Unlock special upgrade rates for a limited period. Start Saving Now →